Cell cycle regulation and differentiation in the human podocyte lineage

Michio Nagata, Keiichi Nakayama, Yoshio Terada, Sachi Hoshi, Teruo Watanabe

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Mature podocytes are regarded as growth-arrested cells with characteristic phenotypic features that underlie their function. To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin- dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry. In S-shaped body stage, Ki-67, a cell proliferation marker that labels the G1/S/G2/M phase, was expressed in the majority (more than 80%) of presumptive podocytes, along with cyclin A (~20% of the Ki-67- positive cells) and cyclin B1 (less than 5% of Ki-67-positive cells) expression. Among these cells, cyclin D1 and CKIs were markedly down- regulated. At the capillary-loop stage, by contrast, CKIs and cyclin D1 were intensely positive in podocytes, whereas no Ki-67, cyclin B1, or cyclin A expression was seen. Moreover, double-immunolabeling and serial-section analysis provided evidence that CKIs and markers specific for differentiating podocytes, namely PHM-5 (podocalyxin-like protein in humans), synaptopodin (a foot process-related protein), and C3b receptor, were co-expressed at the capillary-loop stage. Podocytes were the only cells within the glomeruli that expressed CKIs at immunohistochemically detectable levels. Furthermore, bcl- 2 (an apoptosis inhibitory protein) showed a reciprocal expression pattern to that of CKI. These results suggest that 1) the cell cycle of podocytes is regulated by cyclin and CKIs, 2) CKIs may act to arrest the cell cycle in podocytes at the capillary-loop stage, and 3) the specific cell cycle system in podocytes may be closely correlated with their terminal differentiation in humans.

Original languageEnglish
Pages (from-to)1511-1520
Number of pages10
JournalAmerican Journal of Pathology
Volume153
Issue number5
DOIs
Publication statusPublished - Jan 1 1998

Fingerprint

Podocytes
Cell Differentiation
Cell Cycle
Cyclin-Dependent Kinases
Cyclin B1
Cyclin A
Cyclin D1
Cyclin-Dependent Kinase Inhibitor p57
Complement 3b Receptors
Cyclin-Dependent Kinase 2
Cyclin-Dependent Kinase Inhibitor p27
Cyclins
G2 Phase
Cell Cycle Checkpoints
Cell Division
Foot
Proteins
Immunohistochemistry
Cell Proliferation
Apoptosis

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Cell cycle regulation and differentiation in the human podocyte lineage. / Nagata, Michio; Nakayama, Keiichi; Terada, Yoshio; Hoshi, Sachi; Watanabe, Teruo.

In: American Journal of Pathology, Vol. 153, No. 5, 01.01.1998, p. 1511-1520.

Research output: Contribution to journalArticle

Nagata, Michio ; Nakayama, Keiichi ; Terada, Yoshio ; Hoshi, Sachi ; Watanabe, Teruo. / Cell cycle regulation and differentiation in the human podocyte lineage. In: American Journal of Pathology. 1998 ; Vol. 153, No. 5. pp. 1511-1520.
@article{05f6bce2605b4d44b8e1aebae099f49e,
title = "Cell cycle regulation and differentiation in the human podocyte lineage",
abstract = "Mature podocytes are regarded as growth-arrested cells with characteristic phenotypic features that underlie their function. To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin- dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry. In S-shaped body stage, Ki-67, a cell proliferation marker that labels the G1/S/G2/M phase, was expressed in the majority (more than 80{\%}) of presumptive podocytes, along with cyclin A (~20{\%} of the Ki-67- positive cells) and cyclin B1 (less than 5{\%} of Ki-67-positive cells) expression. Among these cells, cyclin D1 and CKIs were markedly down- regulated. At the capillary-loop stage, by contrast, CKIs and cyclin D1 were intensely positive in podocytes, whereas no Ki-67, cyclin B1, or cyclin A expression was seen. Moreover, double-immunolabeling and serial-section analysis provided evidence that CKIs and markers specific for differentiating podocytes, namely PHM-5 (podocalyxin-like protein in humans), synaptopodin (a foot process-related protein), and C3b receptor, were co-expressed at the capillary-loop stage. Podocytes were the only cells within the glomeruli that expressed CKIs at immunohistochemically detectable levels. Furthermore, bcl- 2 (an apoptosis inhibitory protein) showed a reciprocal expression pattern to that of CKI. These results suggest that 1) the cell cycle of podocytes is regulated by cyclin and CKIs, 2) CKIs may act to arrest the cell cycle in podocytes at the capillary-loop stage, and 3) the specific cell cycle system in podocytes may be closely correlated with their terminal differentiation in humans.",
author = "Michio Nagata and Keiichi Nakayama and Yoshio Terada and Sachi Hoshi and Teruo Watanabe",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)65739-2",
language = "English",
volume = "153",
pages = "1511--1520",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Cell cycle regulation and differentiation in the human podocyte lineage

AU - Nagata, Michio

AU - Nakayama, Keiichi

AU - Terada, Yoshio

AU - Hoshi, Sachi

AU - Watanabe, Teruo

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Mature podocytes are regarded as growth-arrested cells with characteristic phenotypic features that underlie their function. To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin- dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry. In S-shaped body stage, Ki-67, a cell proliferation marker that labels the G1/S/G2/M phase, was expressed in the majority (more than 80%) of presumptive podocytes, along with cyclin A (~20% of the Ki-67- positive cells) and cyclin B1 (less than 5% of Ki-67-positive cells) expression. Among these cells, cyclin D1 and CKIs were markedly down- regulated. At the capillary-loop stage, by contrast, CKIs and cyclin D1 were intensely positive in podocytes, whereas no Ki-67, cyclin B1, or cyclin A expression was seen. Moreover, double-immunolabeling and serial-section analysis provided evidence that CKIs and markers specific for differentiating podocytes, namely PHM-5 (podocalyxin-like protein in humans), synaptopodin (a foot process-related protein), and C3b receptor, were co-expressed at the capillary-loop stage. Podocytes were the only cells within the glomeruli that expressed CKIs at immunohistochemically detectable levels. Furthermore, bcl- 2 (an apoptosis inhibitory protein) showed a reciprocal expression pattern to that of CKI. These results suggest that 1) the cell cycle of podocytes is regulated by cyclin and CKIs, 2) CKIs may act to arrest the cell cycle in podocytes at the capillary-loop stage, and 3) the specific cell cycle system in podocytes may be closely correlated with their terminal differentiation in humans.

AB - Mature podocytes are regarded as growth-arrested cells with characteristic phenotypic features that underlie their function. To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin- dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry. In S-shaped body stage, Ki-67, a cell proliferation marker that labels the G1/S/G2/M phase, was expressed in the majority (more than 80%) of presumptive podocytes, along with cyclin A (~20% of the Ki-67- positive cells) and cyclin B1 (less than 5% of Ki-67-positive cells) expression. Among these cells, cyclin D1 and CKIs were markedly down- regulated. At the capillary-loop stage, by contrast, CKIs and cyclin D1 were intensely positive in podocytes, whereas no Ki-67, cyclin B1, or cyclin A expression was seen. Moreover, double-immunolabeling and serial-section analysis provided evidence that CKIs and markers specific for differentiating podocytes, namely PHM-5 (podocalyxin-like protein in humans), synaptopodin (a foot process-related protein), and C3b receptor, were co-expressed at the capillary-loop stage. Podocytes were the only cells within the glomeruli that expressed CKIs at immunohistochemically detectable levels. Furthermore, bcl- 2 (an apoptosis inhibitory protein) showed a reciprocal expression pattern to that of CKI. These results suggest that 1) the cell cycle of podocytes is regulated by cyclin and CKIs, 2) CKIs may act to arrest the cell cycle in podocytes at the capillary-loop stage, and 3) the specific cell cycle system in podocytes may be closely correlated with their terminal differentiation in humans.

UR - http://www.scopus.com/inward/record.url?scp=0031738382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031738382&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)65739-2

DO - 10.1016/S0002-9440(10)65739-2

M3 - Article

VL - 153

SP - 1511

EP - 1520

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -